HDAC 6 inhibitors (Kancera)

N/A

Report date: 2025/01/26 19:14:34
NME

Base Information

Drug NameHDAC 6 inhibitors (Kancera)
Drug Alias NameHDAC 6 inhibitors (Kancera)HDAC 6 inhibitors (Grünenthal)HDAC 6 inhibitors (Kancera)KAN-0440262
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 6 inhibitors
TargetsHistone deacetylase 6
Therapy Area/IndicationsFibrosisNeuralgiaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKancera AB
China Registration ClassN/A

Develop Information

Active CompaniesKancera AB
Inactive CompaniesGrunenthal Gmbh
Active IndicationsNeuralgiaNeoplasms
Inactive IndicationsFibrosis

Other Information

ATC CodeN/A
Related LinksN/A